Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

NCT02684461

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UNC Lineberger Comprehsive Cancer Center Chapel Hill, North Carolina, United States
  • Rex Cancer Center Raleigh, North Carolina, United States
  • Rex Cancer Center of Wakefield Raleigh, North Carolina, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

Osimertinib in Subjects With Advanced Non-Small Cell Lung Cancer EGFR-T790M Mutation-positive

NCT03790397

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ICO Badalona Badalona, Barcelona, Spain
  • Hospital Clínico Universitario de Santiago Santiago de Compostela, Galicia, Spain
  • Complejo Hospitalario Universitario A Coruña A Coruña, La Coruña, Spain
  • Hospital Universitario Dr. Negrín Las Palmas de Gran Canaria, Las Palmas, Spain
View all 31 locations
View Trial Details
Completed

A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy

NCT03270176

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Cross Cancer Center Dept Medicine Edmonton, Alberta, Canada
  • British Columbia Cancer Agency Vancouver, British Columbia, Canada
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • The Ottawa Hospital Cancer Centre (TOHCC) Ottawa, Ontario, Canada
View Trial Details
Completed

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

NCT03365791

Conditions
Adenocarcinoma Of Esophagus, Advanced Well-differentiated Neuroendocrine Tumors, Bronchial Neoplasms, +28 more
Locations
  • California Pacific Medical Center Drug Shipment (2) San Francisco, California, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer and Blood Center, LLC Athens, Georgia, United States
  • Northwestern University Medical School Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

Immune Boost In Non-Small Cell Lung Cancer

NCT02319408

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Department of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg Heidelberg, Germany
  • German Cancer Research Centre and Clinic for Radiation Oncology of the University of Heidelberg Heidelberg, Germany
View Trial Details
Completed

Navelbine And Radiotherapy in Locally Advanced Lung Cancer

NCT00887783

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Department of Oncology, Aalborg University Hospital Aalborg, Denmark
  • Department of Oncology, Aarhus University Hospital Aarhus, Denmark
  • Department of Oncology, Copenhagen University Hospital Herlev Herlev, Denmark
  • Department of Oncology, Odense University Hospital Odense, Denmark
View Trial Details
Completed

BPI-7711 Capsule in Patients With EGFR Mutation T790M Positive Non-small Cell Lung Cancer

NCT03386955

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Jiangsu Province Hospital Nanjing, Jiangsu, China
  • The First Affiliated Hospital of Suzhou University Suzhou, Jiangsu, China
View Trial Details
Completed

Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib

NCT00522145

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Ronald Yanagihara Gilroy, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • Oncology Division and General Clincial Research, Stanford University Medical Center Stanford, California, United States
  • Cancer Care Center, Inc. P.C. New Albany, Indiana, United States
View Trial Details

Related conditions